Healthcare -
Biotechnology - NASDAQ - US
$ 2.72
-1.45 %
$ 189 M
Market Cap
-0.87
P/E
IKT - PRE-TAX INCOME
Pre-tax Income IKT - Inhibikase Therapeutics, Inc.
-19 M
LAST VALUE
-13.44%
2 YEAR CAGR
-54.63%
5 YEAR CAGR
0.00%
10 YEAR CAGR